封面
市場調查報告書
商品編碼
1878156

全球維生素D市場-2025-2030年預測

Global Vitamin D Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球維生素 D 市場預計將從 2025 年的 17.67 億美元成長到 2030 年的 23.51 億美元,複合年成長率為 5.88%。

維生素D是一種脂溶性維生素,對維持最佳生理功能和整體健康至關重要。市面上主要有兩種生物活性形式的維生素D:維生素D3(膽鈣化醇),提取自魚油、蛋黃和乳製品等動物性產品;以及維生素D2(麥角鈣化醇)。維生素D3在人體對鈣和磷的吸收中發揮著特別重要的作用,支持骨骼礦化和免疫系統功能等基本生理過程。商業性的維生素D3產品有多種標準化濃度,並以油基和粉劑形式供應,適用於包括成人、孕婦和兒童在內的各類消費族群。

全球維生素D市場的擴張是由多種關鍵因素共同推動的。消費者對維生素D營養健康益處的認知不斷提高、已開發市場可支配收入的成長以及產品在各種零售和醫藥分銷管道的廣泛普及,為市場成長奠定了堅實的基礎。尤其值得注意的是,消費者在預防性醫療保健方面的支出不斷增加,尤其是在已開發地區,加速了維生素D補充劑的普及。政府主導的食品強化計畫進一步塑造了這個市場環境,改變了膳食補充劑的市場結構。產品設計日益精細化,針對特定族群的產品不斷湧現,例如孕產婦營養、老年人健康和兒童營養補充品。越來越多的科學證據支持維生素補充劑的益處,這也提振了產業信心,並推動了監管部門的核准,從而創造了有利的市場環境。

全球骨質疏鬆症盛行率的不斷上升,為相關市場帶來了巨大的機會。骨質疏鬆症的特徵是骨骼密度降低和骨微結構劣化,增加骨折風險。此疾病在停經後婦女中特別常見,其風險因子包括遺傳傾向、低體重指數(BMI)和荷爾蒙變化。維生素D在鈣和磷的吸收中發揮著至關重要的作用,是維持骨骼健康和控制該族群骨質疏鬆症的基礎。大量患者的需求持續旺盛,使得維生素D治療和預防補充劑的需求量龐大。

同時,產品研發創新正成為推動市場發展的強大動力。市場擴張主要得益於先進速效維生素D製劑的推出,與傳統補充劑相比,這些製劑具有更高的生物利用度和更快的療效。這些新一代產品旨在有效糾正嚴重的維生素D缺乏症,並縮短患者的康復時間。領先的製造商正優先研發這些速效補充劑以搶佔市場佔有率,因為它們已證明能更快地達到治療所需的血液濃度,從而更快地支持諸如最佳化免疫功能等目標的實現。

按地區分類,亞太地區佔據最大的市場佔有率,預計在整個預測期內將保持主導地位。該地區的成長主要得益於豐富的原料供應,尤其是乳製品產業的原料供應,以及消費者可支配收入的穩定成長。此外,該地區獨特的健康挑戰,例如某些國家非傳染性疾病蔓延導致的高維生素D缺乏症發病率,也為治療性和預防性維生素D產品創造了巨大的市場機會。

北美市場預計也將迎來顯著成長,主要驅動力是消費者對維生素D健康益處的認知不斷提高。然而,該地區也面臨嚴峻的營養挑戰,由於飲食攝取不足,維生素D缺乏症的病例屢見不鮮。這項公共衛生挑戰將顯著推高對維生素D補充劑和強化食品的需求,從而確保該地區市場強勁且持續成長。

本報告的主要優勢:

  • 深入分析:提供對主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局:了解全球主要參與者的策略舉措,並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢:探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議:利用這些見解,在快速變化的環境中製定策略決策,發展新的商業機會和收入來源。
  • 受眾廣泛:適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業,且經濟實惠。

您打算如何使用這份報告?

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

研究範圍:

  • 2022年至2024年的歷史數據和2025年至2030年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區分類的收入成長和預測評估,包括國家/地區
  • 公司概況(策略、產品、財務資訊、關鍵發展等)

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍

第2章 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 全球維生素D市場(以類似物類型分類)

  • 介紹
  • 維生素D2
  • 維生素D3

6. 全球維生素D市場依應用領域分類

  • 介紹
  • 動物飼料和寵物食品
  • 功能性食品和飲料
  • 個人護理
  • 製藥

7. 全球維生素D市場(以最終用戶分類)

  • 介紹
  • 兒童
  • 成人
  • 孕婦

8. 全球維生素D市場(按地區分類)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • BASF
  • DSM
  • Fermenta Biotech Ltd.
  • Zhejiang Medicine Co., Ltd.
  • Zhejiang Garden Biochemical High-Tech Co., Ltd
  • Glanbia
  • Nestle SA
  • Pfizer, Inc.
  • Zhejiang Xinhecheng Co., Ltd
  • McKinley Resources Inc.

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061614494

The global vitamin D market is expected to grow at a 5.88% CAGR, achieving USD 2.351 billion by 2030 from USD 1.767 billion in 2025.

Vitamin D is an essential fat-soluble vitamin critical for optimal physiological function and the maintenance of overall health. The commercial market is primarily composed of two bioactive forms: vitamin D3 (cholecalciferol), which is sourced from animal-derived products such as fish oils, egg yolks, and dairy, and vitamin D2 (ergocalciferol). Vitamin D3 plays a particularly vital role in the body's absorption of calcium and phosphorus, thereby supporting fundamental processes like bone mineralization and immune system function. Commercially, vitamin D3 is formulated into standardized potencies and is available in both oil-based and powder delivery systems, targeting a diverse range of consumer segments including adults, pregnant women, and pediatric populations.

The expansion of the global vitamin D market is propelled by a confluence of key factors. Increasing consumer awareness of the nutritional health benefits associated with vitamin D, coupled with rising disposable income in developed markets and widespread product availability across various retail and pharmaceutical distribution channels, forms a strong foundation for growth. A notable trend is the enhanced consumer spending on preventive healthcare, particularly in developed regions, which has accelerated the adoption of vitamin D supplements. This environment has been further shaped by government-mandated food fortification programs, which have transformed the dietary supplement landscape. Formulations are becoming increasingly sophisticated and targeted toward specialized demographic segments, including prenatal and postnatal nutrition, geriatric health, and pediatric supplementation. The growing body of scientific evidence supporting the benefits of vitamin supplementation has also fostered positive industry sentiment and regulatory acceptance, creating a favorable market climate.

A significant and disease-driven market opportunity stems from the increasing global prevalence of osteoporosis, a condition characterized by decreased bone mineral density and compromised bone microarchitecture that leads to a higher risk of fractures. This condition is particularly prevalent among post-menopausal women, with risk factors including genetic predisposition, low body mass index, and hormonal changes. Given vitamin D's essential role in calcium and phosphorus absorption, it is a cornerstone for maintaining bone health and managing osteoporosis in this demographic. The substantial number of individuals affected by this condition creates a persistent and substantial demand for vitamin D therapeutics and preventive supplements.

Concurrently, innovation in product development is acting as a powerful market catalyst. The introduction of advanced, fast-acting vitamin D formulations is driving market expansion by offering improved bioavailability and a faster therapeutic response compared to conventional supplements. These next-generation products are designed to effectively address severe vitamin D deficiencies and accelerate patient recovery timelines. Leading manufacturers are prioritizing the development of these rapid-absorption supplements to capture market share, with such innovations demonstrating significantly faster efficacy in achieving therapeutic serum levels, thereby supporting goals like immune function optimization more rapidly.

From a geographical perspective, the Asia Pacific region maintains the largest market revenue share and is projected to sustain this leadership position throughout the forecast period. Regional growth is underpinned by abundant raw material availability, particularly from the dairy sector, and consistently rising consumer disposable income. Furthermore, specific regional health challenges, such as higher rates of vitamin D deficiency linked to the prevalence of non-communicable diseases in certain countries, create significant market opportunities for both therapeutic and preventive vitamin D products.

The North American market is also anticipated to experience substantial growth, largely driven by increased consumer awareness of the health benefits of vitamin D. However, the region concurrently faces significant nutritional challenges, with widespread vitamin D deficiency reported due to inadequate dietary intake. This public health issue presents a clear demand driver for supplementation and fortified food products, ensuring a dynamic and growing market in the region.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

  • GLOBAL VITAMIN D MARKET BY ANALOG TYPE
  • Vitamin D2
  • Vitamin D3
  • GLOBAL VITAMIN D MARKET BY APPLICATION
  • Animal feed & pet food
  • Functional food & beverages
  • Personal care
  • Pharmaceuticals
  • GLOBAL VITAMIN D MARKET BY END-USER
  • Children
  • Adults
  • Pregnant Women
  • GLOBAL VITAMIN D MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VITAMIN D MARKET BY ANALOG TYPE

  • 5.1. Introduction
  • 5.2. Vitamin D2
  • 5.3. Vitamin D3

6. GLOBAL VITAMIN D MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Animal feed & pet food
  • 6.3. Functional food & beverages
  • 6.4. Personal care
  • 6.5. Pharmaceuticals

7. GLOBAL VITAMIN D MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Children
  • 7.3. Adults
  • 7.4. Pregnant Women

8. GLOBAL VITAMIN D MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. BASF
  • 10.2. DSM
  • 10.3. Fermenta Biotech Ltd.
  • 10.4. Zhejiang Medicine Co., Ltd.
  • 10.5. Zhejiang Garden Biochemical High-Tech Co., Ltd
  • 10.6. Glanbia
  • 10.7. Nestle SA
  • 10.8. Pfizer, Inc.
  • 10.9. Zhejiang Xinhecheng Co., Ltd
  • 10.10. McKinley Resources Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations